Back to Woodline Partners LP Woodline Partners LP

IBRXIBRX
9 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in IMMUNITYBIO INC

Woodline Partners LP holds 2.5M shares of IBRX (IMMUNITYBIO INC), worth $21.9M as of 2026-Q2. The position was decreased (-27.5% shares). IBRX represents 0.1% of Woodline Partners LP's portfolio.

Current Value

$21.9M

Current Shares

2.5M

Total Value Change

+$19.1M

Total Shares Change

+2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.5M
-27.5%
$21.9M0.1%$8.76
0
2026-Q1
Increased
3.4M
+0.0%
$26.4M0.1%$7.67
34
2025-Q4
Decreased
3.4M
-34.9%
$6.8M0.0%$1.98
0
2025-Q3
Increased
5.3M
+53.7%
$13M0.1%$2.46
39
2025-Q2
Increased
3.4M
+0.0%
$9.1M0.0%$2.64
27
2025-Q1
Increased
3.4M
+0.1%
$10.4M0.1%$3.01
28
2024-Q4
Increased
3.4M
+682.7%
$8.8M0.1%$2.56
44
2024-Q3
Increased
439,818
+0.5%
$1.6M0.0%$3.72
26
2024-Q2
New
437,843
-
$2.8M0.0%$6.32
36

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used